Researchers studied 683 breast cancer patients’ preferences for involvement in treatment decision-making. They found that before consultation, most patients preferred shared or patient-directed treatment decision-making. Post-consultation, however, 43 percent of patients’ preferences changed — most changes indicated a preference for patient-directed decisions. Patients who were as involved as they wanted to be or were more involved than they wanted had significantly better decision-related outcomes than patients who were not as involved.
The authors said oncologists should encourage cancer patients to participate in treatment decision-making.
Related Articles on Hospital Oncology:
Ben Venue Laboratories Releases Limited Supply of Cancer Drug to Ease Shortage
CentraState Healthcare in New Jersey Opens $10M Radiation Oncology Suite
Kimmel Cancer Center at Jefferson in Philadelphia Creates Center to Eliminate Cancer Disparities
